Yellow Fever: A Perennial Threat.

Humans Yellow Fever / epidemiology Yellow Fever Vaccine Yellow fever virus Disease Outbreaks / prevention & control Vaccination
Aedes aegypti Aedes albopictus Hemagogus Vaccine Vaccine-preventable diseases Yellow fever

Journal

Archives of medical research
ISSN: 1873-5487
Titre abrégé: Arch Med Res
Pays: United States
ID NLM: 9312706

Informations de publication

Date de publication:
11 2022
Historique:
received: 05 08 2022
accepted: 13 10 2022
entrez: 21 11 2022
pubmed: 22 11 2022
medline: 23 11 2022
Statut: ppublish

Résumé

Despite the availability of a safe and effective vaccine, yellow fever remains a major vaccine-preventable disease in endemic regions. Additionally, travelers risk acquiring yellow fever when visiting areas of endemic transmission or locations with ongoing outbreaks. Yellow fever is a viral hemorrhagic fever that has inflicted stigma, illness, and death among human societies. From the 17

Identifiants

DOI: 10.1016/j.arcmed.2022.10.005 PMID: 36404585
pubmed: 36404585
pii: S0188-4409(22)00126-6
doi: 10.1016/j.arcmed.2022.10.005
pii:
doi:

Substances chimiques

Yellow Fever Vaccine 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

649-657

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Jose Tuells (J)

Department of Community Nursing, Preventive Medicine and Public Health and History of Science, University of Alicante, San Vicente del Raspeig, Alicante, Spain. Electronic address: tuells@ua.es.

Andrés F Henao-Martínez (AF)

Division of Infectious Diseases, University of Colorado, Anschutz Medical Center, Aurora CO, USA.

Carlos Franco-Paredes (C)

Hospital Infantil de México, Federico Gomez, Ciudad de México, México.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Yellow Fever: A Perennial Threat.
questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ARN › Fièvres hémorragiques virales › Fièvre jaune › Yellow Fever: A Perennial Threat.
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antiviraux › Vaccin antiamaril › Yellow Fever: A Perennial Threat.
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Flaviviridae › Flavivirus › Virus de la fièvre jaune › Yellow Fever: A Perennial Threat.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Yellow Fever: A Perennial Threat.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Prévention primaire › Immunisation › Vaccination › Yellow Fever: A Perennial Threat.